Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
About Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biogen
3
Boehringer Ingelheim
1
Uppsala University
1
Clinical Trials at Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
During the past decade, Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-09-15
2019-08-05
Terminated
1,643
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
2017-02-15
2023-06-30
Active, not recruiting
888
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease
2018-05-03
2021-08-30
Terminated
654
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696
A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction
2021-11-09
2022-05-31
Terminated
5
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus"
#1 collaborator was "The Swedish Stroke Register (Riksstroke)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
According to Clinical.Site data, the most researched conditions in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are
"Alzheimer's Disease" (3 trials), "Atrial Fibrillation" (1 trials), "Fibrostenotic Crohn´s Disease" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" in a lesser frequency.
Clinical Trials Intervention Types at Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
Most popular intervention types in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials), "BIIB092" (1 trials) and "Early start of NOAC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
The vast majority of trials in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus" are
5 trials for "All" genders.
Clinical Trials Status at Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus
Currently, there are NaN active trials in "Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".